Your browser doesn't support javascript.
loading
European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus on the Diagnosis, Service Provision, and Care of People with ME/CFS in Europe.
Nacul, Luis; Authier, François Jérôme; Scheibenbogen, Carmen; Lorusso, Lorenzo; Helland, Ingrid Bergliot; Martin, Jose Alegre; Sirbu, Carmen Adella; Mengshoel, Anne Marit; Polo, Olli; Behrends, Uta; Nielsen, Henrik; Grabowski, Patricia; Sekulic, Slobodan; Sepulveda, Nuno; Estévez-López, Fernando; Zalewski, Pawel; Pheby, Derek F H; Castro-Marrero, Jesus; Sakkas, Giorgos K; Capelli, Enrica; Brundsdlund, Ivan; Cullinan, John; Krumina, Angelika; Bergquist, Jonas; Murovska, Modra; Vermuelen, Ruud C W; Lacerda, Eliana M.
Afiliação
  • Nacul L; London School of Hygiene and Tropical Medicine, Faculty of Infectious and Tropical Diseases, London WC1E 7HT, UK.
  • Authier FJ; BC Women's Hospital, Vancouver, BC V6H 3N1, Canada.
  • Scheibenbogen C; Faculty of Medicine Créteil-Paris Est, 94010 Creteil, France.
  • Lorusso L; Institute of Medical Immunology, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
  • Helland IB; Neurology and Stroke Unit-Neuroscience Department-A.S.S.T.-Lecco, 23900 Merate, Italy.
  • Martin JA; National Advisory Unit on CFS/ME, Oslo University Hospital, Rikshospitalet OUS, 0372 Oslo, Norway.
  • Sirbu CA; Chronic Fatigue Unit, Hospital Universitari Vall d'Hebron University Hospital (VHIR), Universitat Autònoma de Barcelona, E-08035 Barcelona, Spain.
  • Mengshoel AM; Central Military Emergency University Hospital, Titu Maiorescu University, 040441 Bucharest, Romania.
  • Polo O; Institute of Health and Society, Medical Faculty, University of Oslo, Box 1089 Blindern, 0317 Oslo, Norway.
  • Behrends U; Bragée ME/CFS Center, 115 26 Stockholm, Sweden.
  • Nielsen H; Department of Pediatrics, School of Medicine, Technical University of Munich, 80333 Munich, Germany.
  • Grabowski P; Privat Hospitalet Danmark, 2920 Charlottenlund, Denmark.
  • Sekulic S; Department of Hematology, Oncology and Tumor Immunology, Institute for Medical Immunology, Charite Medical School, 10117 Berlin, Germany.
  • Sepulveda N; Medical Faculty Novi Sad, University of Novi Sad, 21000 Novi Sad, Serbia.
  • Estévez-López F; Centre of Statistics and Its Applications, University of Lisbon, 1749-016 Lisbon, Portugal.
  • Zalewski P; Erasmus MC University Medical Center, 3015 Rotterdam, The Netherlands.
  • Pheby DFH; Department of Hygiene, Epidemiology, Ergonomics and Postgraduate Education, Nicolaus Copernicus University in Torun, Collegium Medicum, 85-067 Bydgoszcz, Poland.
  • Castro-Marrero J; Society and Health, Buckinghamshire New University (retired), High Wycombe HP11 2JZ, UK.
  • Sakkas GK; Division of Rheumatology, ME/CFS Research Unit (Lab 009-Box 02), Vall d'Hebron Hospital Research Institute (VHIR), Val d'Hebron Hospital Research Unit (VIHR), Passeig de la Val d'Hebron 119-129, E-08035 Barcelona, Spain.
  • Capelli E; Department of PE and Sports Science, University of Thessaly, 421 00 Trikala, Greece.
  • Brundsdlund I; Department of Earth and Environmental Sciences, University of Pavia, 27100 Pavia, Italy.
  • Cullinan J; Department of Regional Health Research, University Hospital of Southern Denmark, 5000 Odense, Denmark.
  • Krumina A; School of Business & Economics, National University of Ireland Galway, University Road, H91 TK33 Galway, Ireland.
  • Bergquist J; Department of Infectiology and Dermatology, Riga Stradins University, LV-1067 Riga, Latvia.
  • Murovska M; Department of Chemistry-Biomedical Center, Analytical Chemistry and Neuro Chemistry, Uppsala University, 751 23 Uppsala, Sweden.
  • Vermuelen RCW; The Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centre, Uppsala University, 751 23 Uppsala, Sweden.
  • Lacerda EM; Institute of Microbiology and Virology, Riga Stradins University, LV-1067 Riga, Latvia.
Medicina (Kaunas) ; 57(5)2021 May 19.
Article em En | MEDLINE | ID: mdl-34069603
Designed by a group of ME/CFS researchers and health professionals, the European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE) has received funding from the European Cooperation in Science and Technology (COST)-COST action 15111-from 2016 to 2020. The main goal of the Cost Action was to assess the existing knowledge and experience on health care delivery for people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) in European countries, and to enhance coordinated research and health care provision in this field. We report our findings and make recommendations for clinical diagnosis, health services and care for people with ME/CFS in Europe, as prepared by the group of clinicians and researchers from 22 countries and 55 European health professionals and researchers, who have been informed by people with ME/CFS.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Síndrome de Fadiga Crônica Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Medicina (Kaunas) Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Síndrome de Fadiga Crônica Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Medicina (Kaunas) Assunto da revista: MEDICINA Ano de publicação: 2021 Tipo de documento: Article